HPV-related cancers after solid organ transplantation in the United States

American Journal of Transplantation

Volumn 13, Issue 12, 2013, Pages 3202-3209

  Madeleine, M M ^a,b   Finch, J L ^c   Lynch, C F ^d   Goodman, M T ^e   Engels, E A ^f  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c Air Pollution Control Division   (United States)

^d UNIVERSITY OF IOWA   (United States)

^e CEDARS SINAI MEDICAL CENTER   (United States)

^f NATIONAL CANCER INSTITUTE   (United States)

Author keywords

HPV related cancer; Immunosuppression; Organ transplant cohort; Transplant Cancer Match Study

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN; HLA DRB1 ANTIGEN; MYCOPHENOLIC ACID; RAPAMYCIN; TACROLIMUS;

ADULT; ANUS CANCER; ARTICLE; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER RISK; CANCER SCREENING; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; FEMALE; GRAFT RECIPIENT; GRAFT REJECTION; HUMAN; IMMUNOPHENOTYPING; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; MALE; ORGAN TRANSPLANTATION; OROPHARYNX CANCER; PENIS CANCER; PRIORITY JOURNAL; STANDARDIZED INCIDENCE RATIO; UNITED STATES; UTERINE CERVIX CANCER; VULVA CANCER; WART VIRUS;

HPV-RELATED CANCER; IMMUNOSUPPRESSION; ORGAN TRANSPLANT COHORT; TRANSPLANT CANCER MATCH STUDY;

ADOLESCENT; ADULT; ANUS NEOPLASMS; COHORT STUDIES; FEMALE; HUMANS; IMMUNOSUPPRESSION; INCIDENCE; MALE; MIDDLE AGED; ORGAN TRANSPLANTATION; OROPHARYNGEAL NEOPLASMS; PAPILLOMAVIRUS INFECTIONS; PENILE NEOPLASMS; REGISTRIES; TACROLIMUS; UNITED STATES; UTERINE CERVICAL NEOPLASMS; VULVAR NEOPLASMS; YOUNG ADULT;

EID: 84888337367     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.12472     Document Type: Article

References (30)

1. Euvrard S, Kanitakis J, Claudy A., Skin cancers after organ transplantation. N Engl J Med 2003; 348: 1681-1691.
2. Parkin DM, Bray F., Chapter 2: The burden of HPV-related cancers. Vaccine 2006; 24 (Suppl 3): S11-S25.
3. Bouvard V, Baan R, Straif K, et al. A review of human carcinogens-Part B: Biological agents. Lancet Oncol 2009; 10: 321-322.
4. Grulich AE, van Leeuwen MT, Falster MO, Vajdic CM., Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: A meta-analysis. Lancet 2007; 370: 59-67.
5. Collett D, Mumford L, Banner NR, Neuberger J, Watson C., Comparison of the incidence of malignancy in recipients of different types of organ: A UK Registry audit. Am J Transplant 2010; 10: 1889-1896.
6. Engels EA, Pfeiffer RM, Fraumeni JF Jr., et al. Spectrum of cancer risk among US solid organ transplant recipients. JAMA 2011; 306: 1891-1901.
7. Chaturvedi AK, Engels EA, Anderson WF, Gillison ML., Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. J Clin Oncol 2008; 26: 612-619.
8. Hildesheim A, Wang SS., Host and viral genetics and risk of cervical cancer: A review. Virus Res 2002; 89: 229-240.
9. Madeleine MM, Johnson LG, Smith AG, et al. Comprehensive analysis of HLA-A, HLA-B, HLA-C, HLA-DRB1, and HLA-DQB1 loci and squamous cell cervical cancer risk. Cancer Res 2008; 68: 3532-3539.
10. Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999; 189: 12-19.
11. Kreimer AR, Clifford GM, Boyle P, Franceschi S., Human papillomavirus types in head and neck squamous cell carcinomas worldwide: A systematic review. Cancer Epidemiol Biomarkers Prev 2005; 14: 467-475.
12. Moscicki AB, Schiffman M, Kjaer S, Villa LL., Chapter 5: Updating the natural history of HPV and anogenital cancer. Vaccine 2006; 24: S3-42-S3/51.
13. Daling JR, Madeleine MM, Johnson LG, et al. Human papillomavirus, smoking, and sexual practices in the etiology of anal cancer. Cancer 2004; 101: 270-280.
14. Chaturvedi AK, Madeleine MM, Biggar RJ, Engels EA., Risk of human papillomavirus-associated cancers among persons with AIDS. J Natl Cancer Inst 2009; 101: 1120-1130.
15. Opelz G, Dohler B., Effect of human leukocyte antigen compatibility on kidney graft survival: Comparative analysis of two decades. Transplantation 2007; 84: 137-143.
16. D'Souza G, Kreimer AR, Viscidi R, et al. Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med 2007; 356: 1944-1956.
17. Duvoux C, Delacroix I, Richardet JP, et al. Increased incidence of oropharyngeal squamous cell carcinomas after liver transplantation for alcoholic cirrhosis. Transplantation 1999; 67: 418-421.
18. Meier-Kriesche HU, Li S, Gruessner RW, et al. Immunosuppression: Evolution in practice and trends, 1994-2004. Am J Transplant 2006; 6: 1111-1131.
19. OPTN. The Organ Procurement and Transplantation Network (OPTN) maintains the only national patient waitinglist and features the most comprehensive data available in any single field of medicine. US Department of Health and Human Services 2011. Available at: http://optn.transplant.hrsa.gov/. Accessed Jul 5, 2011.
20. Almawi WY, Melemedjian OK., Clinical and mechanistic differences between FK506 (tacrolimus) and cyclosporin A. Nephrol Dial Transplant 2000; 15: 1916-1918.
21. Karagas MR, Cushing GL Jr., Greenberg ER, Mott LA, Spencer SK, Nierenberg DW., Non-melanoma skin cancers and glucocorticoid therapy. Br J Cancer 2001; 85: 683-686.
22. Mathew T, Kreis H, Friend P., Two-year incidence of malignancy in sirolimus-treated renal transplant recipients: Results from five multicenter studies. Clin Transplant 2004; 18: 446-449.
23. Euvrard S, Morelon E, Rostaing L, et al. Sirolimus and secondary skin-cancer prevention in kidney transplantation. N Engl J Med 2012; 367: 329-339.
24. Moyer VA., Screening for cervical cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2012; 156: 880-891, W312.
25. Kasiske BL, Zeier MG, Chapman JR, et al. KDIGO clinical practice guideline for the care of kidney transplant recipients: A summary. Kidney Int 2010; 77: 299-311.
26. Wong G, Chapman JR, Craig JC., Cancer screening in renal transplant recipients: What is the evidence ? Clin J Am Soc Nephrol 2008; 3: S87-S100.
27. Etienney I, Vuong S, Si-Mohamed A, Flejou JF, Atienza P, Bauer P., Value of cytologic Papanicolaou smears and polymerase chain reaction screening for human papillomavirus DNA in detecting anal intraepithelial neoplasia: Comparison with histology of a surgical sample. Cancer 2012; 118: 6031-6038.
28. Goldie SJ, Kuntz KM, Weinstein MC, Freedberg KA, Welton ML, Palefsky JM., The clinical effectiveness and cost-effectiveness of screening for anal squamous intraepithelial lesions in homosexual and bisexual HIV-positive men. JAMA 1999; 281: 1822-1829.
29. Patel HS, Silver AR, Northover JM., Anal cancer in renal transplant patients. Int J Colorectal Dis 2007; 22: 1-5.
30. Walts AE, Thomas P, Bose S., Anal cytology: Is there a role for reflex HPV DNA testing ? Diagn Cytopathol 2005; 33: 152-156.